valsartan/hydrochlorothiazide 80 mg/ 12.5 mg film-coated tablets
actavis group ptc ehf - valsartan; hydrochlorothiazide - film-coated tablet - 80/12.5 mg/mg - angiotensin ii antagonists and diuretics; valsartan and diuretics
valsartan teva 80 mg film-coated tablets
teva pharma b.v. - valsartan - film-coated tablet - 80 milligram(s) - angiotensin ii antagonists, plain; valsartan
valtan 80 mg film-coated tablets
clonmel healthcare ltd - valsartan - film-coated tablet - 80 milligram(s) - angiotensin ii antagonists, plain; valsartan
valsacor h 80 tablets film-coated
krka d.d. - valsartan, hydrochlorothiazide - tablets film-coated - 80mg+ 12,5mg
valsacor h 80 tablets film-coated
krka d.d. - valsartan, hydrochlorothiazide - tablets film-coated - 80mg+ 12,5mg
pharmacor sacubitril valsartan sacubitril/valsartan 49/51 mg film-coated tablet blister pack
pharmacor pty ltd - valsartan, quantity: 51.4 mg; sacubitril, quantity: 48.6 mg - tablet, film coated - excipient ingredients: hyprolose; sodium starch glycollate type a; colloidal anhydrous silica; microcrystalline cellulose; purified talc; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 4000 - pharmacor sacubitril/valsartan is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
pharmacor sacubitril valsartan sacubitril/valsartan 97/103 mg film-coated tablet blister pack
pharmacor pty ltd - sacubitril, quantity: 97.2 mg; valsartan, quantity: 102.8 mg - tablet, film coated - excipient ingredients: hyprolose; purified talc; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - pharmacor sacubitril/valsartan is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
pharmacor sacubitril valsartan sacubitril/valsartan 97/103 mg film-coated tablet bottle pack
pharmacor pty ltd - sacubitril, quantity: 97.2 mg; valsartan, quantity: 102.8 mg - tablet, film coated - excipient ingredients: magnesium stearate; purified talc; microcrystalline cellulose; colloidal anhydrous silica; hyprolose; sodium starch glycollate type a; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - pharmacor sacubitril/valsartan is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
valtresto sacubitril/valsartan 97/103 mg film-coated tablet blister pack
pharmacor pty ltd - sacubitril, quantity: 97.2 mg; valsartan, quantity: 102.8 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; hyprolose; magnesium stearate; purified talc; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.
valtresto sacubitril/valsartan 97/103 mg film-coated tablet bottle pack
pharmacor pty ltd - sacubitril, quantity: 97.2 mg; valsartan, quantity: 102.8 mg - tablet, film coated - excipient ingredients: hyprolose; magnesium stearate; purified talc; microcrystalline cellulose; sodium starch glycollate type a; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - valtresto is indicated in adult patients for the treatment of chronic heart failure (nyha class ii-iv) with reduced ejection fraction.